Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Value Stock, Under Radar
844.2500 3.00 (0.36%)
NSE Sep 10, 2025 15:59 PM
Volume: 492.2K
 

logo
Natco Pharma Ltd.
12 Aug 2019
844.25
0.36%
ICICI Securities Limited
Revenues de-grew 8.6% YoY to | 492.3 crore (I-direct estimate: | 608.2 crore) mainly due to 14.1% decline in domestic formulations to | 164 crore. Export business grew 2.1% YoY to | 241 crore (I-direct estimate: | 262.1 crore). EBITDA margins contracted 154 bps to 38.9% (I-direct estimate: 43.3%) mainly due to high employee cost. EBITDA de-grew 12.1% YoY to | 191.3 crore against I-direct estimate of | 263.5 crore. Net profit de-grew 21.1% YoY to | 143.2 crore (I-direct estimate: | 195.4 crore). Delta vis--vis...
Number of MF schemes decreased from 54 to 47 in Jun 2025 qtr
More from Natco Pharma Ltd.
All Rapid Results
Recommended